Clinical Trial
2018 Oct 27. [Epub ahead of print]
JOURNAL：J Am Coll Cardiol.
Article Link
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial
M Szarek, HD White, PH Steg, ODYSSEY OUTCOMES Committees and Investigators.
KEYWORDS
Alirocumab; acute coronary syndrome; total events
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
